This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medtronic's Fiscal Q4 Non-GAAP Earnings Fall, Net Sales Rise; Fiscal 2025 Guidance Issued; Quarterly Dividend Lifted MT
Stock Futures Climb Pre-Bell Boosted by Nvidia's Financial Results; Asia Falls, Europe Strong MT
Earnings Flash (MDT) MEDTRONIC Posts Q4 Revenue $8.59B, vs. Street Est of $8.44B MT
Earnings Flash (MDT) MEDTRONIC Posts Q4 EPS $1.46, vs. Street Est of $1.45 MT
Transcript : Medtronic plc, Q4 2024 Earnings Call, May 23, 2024
Medtronic: dividend raised with quarterly results CF
Medtronic 4Q Sales Top Forecasts, Issues FY25 Guidance DJ
Medtronic Increases Dividend 1.4% to 70 Cents a Share DJ
Medtronic beats quarterly profit estimates on medical devices strength RE
Medtronic beats quarterly profit estimates on medical devices strength RE
Medtronic plc Reports Earnings Results for the Fourth Quarter Ended April 26, 2024 CI
Medtronic plc Reports Earnings Results for the Full Year Ended April 26, 2024 CI
Medtronic Trial for AFib System Achieves Endpoints DJ
Medtronic Says Small-Diameter Defibrillation Lead Meets Safety, Efficacy Goals in Pivotal Trial MT
Medtronic plc Announces its Investigational OmniaSecure Defibrillation Lead Met its Primary Safety and Effectiveness Endpoints, Existing Safety and Effectiveness Endpoints CI
Departing Boeing CEO's board status faces Friday vote by shareholders RE
Insulet Shares Rise Despite Blue Orca's Short Position MT
Arecor Therapeutics collaborates with Medtronic on novel insulin AN
Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development MT
Arecor and Medtronic Diabetes Collaboration CI
Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain MT
Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator DJ
Medtronic plc Receives FDA Approval for Inceptiv Closed-Loop Spinal Cord Stimulator CI
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength RE
Edwards Lifesciences Corporation: The story continues Our Logo
Chart Medtronic plc
More charts
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.76 USD
Average target price
94.77 USD
Spread / Average Target
+10.51%
Consensus
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. News Medtronic plc
  5. Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development